Targeted Imaging for Cell Death in Cardiovascular Disorders

Aditya Shekhar, Peter Heeger, Chris Reutelingsperger, Eloisa Arbustini, Navneet Narula, Leonard Hofstra, Jeroen J. Bax, Jagat Narula

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Cell death is desirable in cancer cells and undesirable in organs with limited regenerative potential, like the heart. Cell death comes in many forms, but only apoptosis and to a lesser degree necrosis is currently relevant to the clinical imager. Noninvasive imaging of cell death is an attractive option to understand pathophysiology, track disease activity, and evaluate response to intervention. Apoptosis seems to be the most promising target for imaging cell death, because it could be reversible and might be modulated with interventions. Molecular, nuclear, optical, or magnetic resonance imaging-based methods have been developed to identify intermediate steps in the apoptosis cascade. Animal studies show promising results for noninvasive imaging in various cardiovascular diseases. Human studies have shown feasibility, but clinical use is yet inconclusive. Newer technologies offer promise, especially for tracking apoptosis in evaluation of novel therapeutic interventions.

Original languageEnglish
JournalJACC: Cardiovascular Imaging
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Cell Death
Apoptosis
Necrosis
Cardiovascular Diseases
Magnetic Resonance Imaging
Technology
Neoplasms
Therapeutics

Keywords

  • Coronary artery stenosis
  • Myocardial ischemia
  • Revascularization
  • Stable ischemic heart disease
  • Vulnerable plaque

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Shekhar, A., Heeger, P., Reutelingsperger, C., Arbustini, E., Narula, N., Hofstra, L., ... Narula, J. (Accepted/In press). Targeted Imaging for Cell Death in Cardiovascular Disorders. JACC: Cardiovascular Imaging. https://doi.org/10.1016/j.jcmg.2017.11.018

Targeted Imaging for Cell Death in Cardiovascular Disorders. / Shekhar, Aditya; Heeger, Peter; Reutelingsperger, Chris; Arbustini, Eloisa; Narula, Navneet; Hofstra, Leonard; Bax, Jeroen J.; Narula, Jagat.

In: JACC: Cardiovascular Imaging, 01.01.2018.

Research output: Contribution to journalArticle

Shekhar, A, Heeger, P, Reutelingsperger, C, Arbustini, E, Narula, N, Hofstra, L, Bax, JJ & Narula, J 2018, 'Targeted Imaging for Cell Death in Cardiovascular Disorders', JACC: Cardiovascular Imaging. https://doi.org/10.1016/j.jcmg.2017.11.018
Shekhar, Aditya ; Heeger, Peter ; Reutelingsperger, Chris ; Arbustini, Eloisa ; Narula, Navneet ; Hofstra, Leonard ; Bax, Jeroen J. ; Narula, Jagat. / Targeted Imaging for Cell Death in Cardiovascular Disorders. In: JACC: Cardiovascular Imaging. 2018.
@article{086a5d1200c747bd8b0deb39a8fbcbfe,
title = "Targeted Imaging for Cell Death in Cardiovascular Disorders",
abstract = "Cell death is desirable in cancer cells and undesirable in organs with limited regenerative potential, like the heart. Cell death comes in many forms, but only apoptosis and to a lesser degree necrosis is currently relevant to the clinical imager. Noninvasive imaging of cell death is an attractive option to understand pathophysiology, track disease activity, and evaluate response to intervention. Apoptosis seems to be the most promising target for imaging cell death, because it could be reversible and might be modulated with interventions. Molecular, nuclear, optical, or magnetic resonance imaging-based methods have been developed to identify intermediate steps in the apoptosis cascade. Animal studies show promising results for noninvasive imaging in various cardiovascular diseases. Human studies have shown feasibility, but clinical use is yet inconclusive. Newer technologies offer promise, especially for tracking apoptosis in evaluation of novel therapeutic interventions.",
keywords = "Coronary artery stenosis, Myocardial ischemia, Revascularization, Stable ischemic heart disease, Vulnerable plaque",
author = "Aditya Shekhar and Peter Heeger and Chris Reutelingsperger and Eloisa Arbustini and Navneet Narula and Leonard Hofstra and Bax, {Jeroen J.} and Jagat Narula",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.jcmg.2017.11.018",
language = "English",
journal = "JACC: Cardiovascular Imaging",
issn = "1936-878X",
publisher = "NLM (Medline)",

}

TY - JOUR

T1 - Targeted Imaging for Cell Death in Cardiovascular Disorders

AU - Shekhar, Aditya

AU - Heeger, Peter

AU - Reutelingsperger, Chris

AU - Arbustini, Eloisa

AU - Narula, Navneet

AU - Hofstra, Leonard

AU - Bax, Jeroen J.

AU - Narula, Jagat

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Cell death is desirable in cancer cells and undesirable in organs with limited regenerative potential, like the heart. Cell death comes in many forms, but only apoptosis and to a lesser degree necrosis is currently relevant to the clinical imager. Noninvasive imaging of cell death is an attractive option to understand pathophysiology, track disease activity, and evaluate response to intervention. Apoptosis seems to be the most promising target for imaging cell death, because it could be reversible and might be modulated with interventions. Molecular, nuclear, optical, or magnetic resonance imaging-based methods have been developed to identify intermediate steps in the apoptosis cascade. Animal studies show promising results for noninvasive imaging in various cardiovascular diseases. Human studies have shown feasibility, but clinical use is yet inconclusive. Newer technologies offer promise, especially for tracking apoptosis in evaluation of novel therapeutic interventions.

AB - Cell death is desirable in cancer cells and undesirable in organs with limited regenerative potential, like the heart. Cell death comes in many forms, but only apoptosis and to a lesser degree necrosis is currently relevant to the clinical imager. Noninvasive imaging of cell death is an attractive option to understand pathophysiology, track disease activity, and evaluate response to intervention. Apoptosis seems to be the most promising target for imaging cell death, because it could be reversible and might be modulated with interventions. Molecular, nuclear, optical, or magnetic resonance imaging-based methods have been developed to identify intermediate steps in the apoptosis cascade. Animal studies show promising results for noninvasive imaging in various cardiovascular diseases. Human studies have shown feasibility, but clinical use is yet inconclusive. Newer technologies offer promise, especially for tracking apoptosis in evaluation of novel therapeutic interventions.

KW - Coronary artery stenosis

KW - Myocardial ischemia

KW - Revascularization

KW - Stable ischemic heart disease

KW - Vulnerable plaque

UR - http://www.scopus.com/inward/record.url?scp=85041122867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041122867&partnerID=8YFLogxK

U2 - 10.1016/j.jcmg.2017.11.018

DO - 10.1016/j.jcmg.2017.11.018

M3 - Article

AN - SCOPUS:85041122867

JO - JACC: Cardiovascular Imaging

JF - JACC: Cardiovascular Imaging

SN - 1936-878X

ER -